Literature DB >> 17445525

Reliability and validity of the Japanese version of the Anxiety Sensitivity Index.

Toshimasa Maruta1, Taketo Yamate, Kentaro Ito, Mitsuhiko Sato, Makio Iimori, Masaaki Kato.   

Abstract

This preliminary study evaluated the reliability and validity of the Japanese version of the Anxiety Sensitivity Index (ASI). Its test-retest reliability and internal consistency were found acceptable. Factor analysis of the ASI yielded 4 anxiety-related factors: factor I is heart/lung failure concern; factor II, psychological concern; factor III, physical concern; and factor IV, social concern. In addition, multiple regression analysis showed that the ASI score significantly correlated only with the neuroticism-related category of the NEO-Personality Inventory Revised. The ASI mean scores of those with 5 or more according to the General Health Questionnaire (unhealthy) and those with 16 or more according to the Center for Epidemiological Studies Depressive Scale (depression) were significantly higher than in the healthy and nondepressive groups. Although further research is necessary to confirm the construct validity by factor analysis of the ASI, the Japanese version of the ASI is applicable for use in the Japanese population.

Entities:  

Mesh:

Year:  2007        PMID: 17445525     DOI: 10.1016/j.comppsych.2006.12.004

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  2 in total

1.  Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.

Authors:  Michiko Kano; Tomohiko Muratsubaki; Lukas Van Oudenhove; Joe Morishita; Makoto Yoshizawa; Keiji Kohno; Mao Yagihashi; Yukari Tanaka; Shunji Mugikura; Patrick Dupont; Huynh Giao Ly; Kei Takase; Motoyori Kanazawa; Shin Fukudo
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

2.  Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder.

Authors:  Keiko Ino; Sei Ogawa; Masaki Kondo; Risa Imai; Toshitaka Ii; Toshi A Furukawa; Tatsuo Akechi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-13       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.